{"name":"Rolicyclidine","slug":"rolicyclidine","kind":"substance","abbreviations":["PCPy"],"systematic":null,"aliases":["Roliciclidina","Rolicyclidinum","PHP (1-(1-phenylcyclohexyl)pyrrolidine)","Pyrrolidine, 1-(1-phenylcyclohexyl)-","DEA No. 7458","Hsdb 7636","1-(1-phenylcyclohexyl)-pyrrolidine","Pyrrolidine, 1-(1-phenylcyclohexyl)","Db-362666","1-(1-phenylcyclohexyl)pyrrolidine (Rolicyclidine)"],"brands":[],"scraped":true,"has_structure":true,"cid":62436,"classes":[{"name":"anaesthetic","href":"/class/anaesthetic"},{"name":"dissociative","href":"/class/dissociative"}],"families":[{"name":"arylcyclohexylpyrrolidine","href":"/substituted/arylcyclohexylpyrrolidine"}],"physical":[{"label":"Molecular mass","value":"229.36 g/mol","copyable":false},{"label":"Predicted LogP","value":"3.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>16</sub>H<sub>23</sub>N","copyable":true},{"label":"IUPAC name","value":"1-(1-phenylcyclohexyl)pyrrolidine","copyable":true},{"label":"SMILES","value":"C1CCC(CC1)(C2=CC=CC=C2)N3CCCC3","copyable":true},{"label":"InChI","value":"InChI=1S/C16H23N/c1-3-9-15(10-4-1)16(11-5-2-6-12-16)17-13-7-8-14-17/h1,3-4,9-10H,2,5-8,11-14H2","copyable":true},{"label":"InChIKey","value":"FYOWWXMGDATDQY-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"2201-39-0","copyable":true},{"label":"UNII","value":"183O9O9JE3","copyable":true},{"label":"PubChem CID","value":"62436","copyable":true}],"pharmacokinetics":[],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Rolicyclidine works primarily as an NMDA receptor antagonist, which blocks the activity of the NMDA Receptor.","side_effects":null,"effects":null,"usernotes":[{"user":"nervewing","user_slug":"nervewing","external":false,"note":{"substance":"Rolicyclidine","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 9","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"F2","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule III","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class A","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule I","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"Germany","status":"Anlage I","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"United Nations","status":"Schedule I psychotropic","act":"Convention on Psychotropic Substances 1971","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Rolicyclidine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/62436"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q570183"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01549"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1719398"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A60805"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=2201-39-0"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D12706"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8046167"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Rolicyclidine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/183O9O9JE3"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 62436, Rolicyclidine. Accessed November 22, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/62436>https://pubchem.ncbi.nlm.nih.gov/compound/62436</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Rolicyclidine. UNII: 183O9O9JE3. Global Substance Registration System. Accessed November 22, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/183O9O9JE3>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/183O9O9JE3</a>","RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 17:01:46","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 17:01:42","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 17:01:42","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 17:01:42","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 17:01:42","note":"no HMDB id"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 17:01:44","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 17:01:42","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 17:01:42","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 17:01:42","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 17:01:42","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 17:01:42","note":null}],"description":"Rolicyclidine is a anaesthetic, dissociative substance."}